- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02162654
Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment (RIPAT)
The Role of Remote Ischemic Preconditioning in the Prevention of Ischemic Brain Damage During Intracranial Aneurysm Treatment (RIPAT) - A Prospective Randomized Exploratory Study
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Prospective, randomized, double-blind, explorative single center clinical trial in patients subjected to the treatment of an un-ruptured intracranial aneurysm, either by surgical clipping or endovascular coiling. Goal of the study is to determine whether remote ischemic preconditioning (RIPC) prior to aneurysm treatment alters various biomarkers associated with ischemic central neuronal tissue damage. The trial takes place at Innsbruck University Hospital of Innsbruck Medical University, Innsbruck, Austria.
Patients fulfilling inclusion criteria are randomly allocated either to pre-interventional ischemic preconditioning (Group A = intervention group) or sham preconditioning (Group B = control group). RIPC is performed by inflating a blood pressure cuff around one upper extremity three times for five minutes with five minutes interval with the patient under general anesthesia prior to the start of the procedure.
Patients, all staff involved in diagnosis and treatment and all study members are blinded to the patients' group affiliation. The anesthesiologist and two staff members who perform preconditioning are not blinded.
Primary outcome is a difference of ± 2SD in the concentration-time curve of a panel of biochemical parameters indicative of cerebral ischemia (S100B, NSE, GFAP, MMP9, MBP, microparticles) in the first five days after the intervention. Secondary outcome parameters are changes in the post-interventional MRI and neuropsychological and clinical outcome at six and 12 months.
CONSORT and TIDieR guidelines will be followed. The trail will be registered in a public database. The trail protocol will be published in an open-access journal.
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Innsbruck, L'Autriche, 6020
- Recrutement
- Clinical Department of Neurosurgery, Innsbruck Medical University
-
Contact:
- Martin Ortler, M.D., MSc.
- Numéro de téléphone: 80975 0043-512-504
- E-mail: martin.ortler@i-med.ac.at
-
Contact:
- Selma Tülü, Cand. med.
- E-mail: selma.tuelue@student.i-med.ac.at
-
Chercheur principal:
- Martin Ortler, MD, MSc
-
Sous-enquêteur:
- Claudius Thomé, M.D.
-
Sous-enquêteur:
- Selma Tülü, Cand.med.
-
Sous-enquêteur:
- Miriam Mulino, M.D.
-
Sous-enquêteur:
- Daniel Pinggera, M.D.
-
Sous-enquêteur:
- Claudia Unterhofer, M.D.
-
Sous-enquêteur:
- Erich Schmutzhard, M.D.
-
Sous-enquêteur:
- Bettina Pfausler, M.D.
-
Sous-enquêteur:
- Ronny Beer, M.D.
-
Sous-enquêteur:
- Raimund Helbok, M.D.
-
Sous-enquêteur:
- Peter Lackner, M.D.
-
Sous-enquêteur:
- Thomas Benke, M.D.
-
Sous-enquêteur:
- Thomas Bodner, M.D.
-
Sous-enquêteur:
- Margarethe Delazer, M.D.
-
Sous-enquêteur:
- Raffaella Matteucci-Gothe, Ph.D.
-
Sous-enquêteur:
- Uwe Siewert, Ph.D.
-
Sous-enquêteur:
- Philipp Würtinger, M.D.
-
Sous-enquêteur:
- Andrea Griesmacher, M.D.
-
Sous-enquêteur:
- Markus Luger, M.D.
-
Sous-enquêteur:
- Arnulf Benzer, M.D.
-
Sous-enquêteur:
- Franz Wiedermann, M.D.
-
Sous-enquêteur:
- Astrid Grams, M.D.
-
Sous-enquêteur:
- Elke Gizewski, M.D.
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Informed written consent of patient
- Age > 18 years
- Intracranial aneurysm, single or multiple, intervention as indicated by interdisciplinary vascular board (includes previously treated aneurysms)
- Normal baseline MRI
Exclusion Criteria:
- Clinical or radiological signs of subarachnoid hemorrhage
- Planned vessel sacrifice as the primary modality for aneurysm treatment
- Dissecting or mycotic aneurysm
- Previous history of stroke or TIA within the last six months
- Signs or symptoms of upper and lower extremity peripheral vascular illness
- Drugs and lifestyle factors that interfere with biomarker Determination
- Inability to complete neuropsychological testing for language reasons
- Patients unable to have an MRI scan for any reason
- Previous serious cerebral disease that would preclude completion of the protocol or preclude MRI analysis of small strokes
- Pregnancy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Remote ischemic preconditioning
Inflation of a blood pressure cuff around an arm with the patient under general anesthesia prior to start aneurysm treatment
|
The blood pressure cuff is inflated to 200 mmHg for 3 x 5 minutes with 5 minutes of reperfusion by complete cuff deflation each.
|
|
Comparateur factice: Sham preconditioning
Sham inflation of a blood pressure cuff around an arm with the patient under general anesthesia prior to start aneurysm treatment
|
The blood pressure cuff is inflated to 10 mmHg for 3 x 5 minutes with 5 minutes of complete cuff deflation each.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Area-under-Curve for biomarkers in the first 5 days after aneurysm treatment(S100B, NSE, GFAP, NSE, MMP9, Microparticles)
Délai: on admission, after preconditioning but prior to intervention, at completion of intervention, at hours 3, 6, 12, 24, 48, 72, 96, 120 after completion of intervention
|
Serum biomarkers reflect brain tissue ischemic damage with various specificity and sensitivity (see Whiteley 2008, Ahmad 2012) Advantages include (1) to be available early, (2) to be continuous variables (low study n), (3) they were able to demonstrate an effect of ischemic preconditioning in other clinical studies (see Koch 2010, Veighei 2012)
|
on admission, after preconditioning but prior to intervention, at completion of intervention, at hours 3, 6, 12, 24, 48, 72, 96, 120 after completion of intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number (n) of new lesions in postinterventional MRI (DWI and FLAIR)
Délai: preinterventional/on day 1 or 2
|
Outcome Parameter used in other clinical studies focussing on ischemia after neurointerventional procedures (e.g.
ENACT study)
|
preinterventional/on day 1 or 2
|
|
Clinical outcome ( National Institutes of Health Stroke Scale, NIHSS and modified Rankin Scale mRS)
Délai: at discharge, at 6 and 12 months
|
Established outcome parameters for cerebrovascular studies.
Dichotomized into favourable (NIHSS ≤1, mRS 0-1) and unfavourable
|
at discharge, at 6 and 12 months
|
|
Volume (mm3) of new lesions in postinterventional MRI (DWI and FLAIR)
Délai: preinterventional, postinterventional on day 1 or 2
|
As above for number of lesions
|
preinterventional, postinterventional on day 1 or 2
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Neuropsychological testing VLMTA (Verbaler Lern- und Merkfähigkeitstest), the WMS-R (Zahlenspanne vorwärts und rückwärts), trail making A and B tests, the Regensburger Wortflüssigkeitstest, the TAP Wechsel verbal, the TAP and the HADS-D)
Délai: preinterventional, at 6 and 12 months
|
Standard tests used in patients with cerebrovascular disorders in our departments.
Not applicable to non-german-speaking patients.
|
preinterventional, at 6 and 12 months
|
|
Brain volume changes (MRI, voxel -based morphometry)
Délai: Preinterventional/at the 12 months FU
|
Longterm brain volume changes that correlate with NP deficits (Horstmann 2010, Moskowitz 2011, Vuylsteke 2011) will be analyzed using voxel-based morphometry techniques
|
Preinterventional/at the 12 months FU
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Martin Ortler, M.D., MSc., Clinical Department of Neurosurgery, Innsbruck Medical University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 20131101-823
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .